Pryor J P, Castle W M, Dukes D C, Smith J C, Watson M E, Williams J L
Br Med J (Clin Res Ed). 1983 Sep 3;287(6393):639-41. doi: 10.1136/bmj.287.6393.639.
The aetiology of retroperitoneal fibrosis is unknown. From time to time different drugs have been suggested as a cause, including beta adrenoceptor blocking agents. The notes of 100 hospital inpatients in whom retroperitoneal fibrosis had been diagnosed were surveyed to identify the date of onset of symptoms, the drugs prescribed before then, and the blood pressures on admission. Seventy one patients had diastolic pressures on admission of 90 mm Hg or more and 53 of these had pressures of at least 100 mm Hg despite 14 of the patients taking anti-hypertensive drugs at the time. Six patients had received beta-adrenoceptor blocking agents before the onset of symptoms and a further 24 received them subsequently. In particular, three patients continued treatment for at least six years after the diagnosis was made and surgery performed, without suffering a recurrence of retroperitoneal fibrosis. Besides beta-adrenoceptor drugs, diuretics and other hypotensive drugs were taken in amounts reflecting the pattern of drug use among hypertensive patients generally. Rather than being causal agents, the antihypertensive drugs were probably being used to treat hypertension associated with the retroperitoneal fibrosis, and our findings suggest that beta-adrenoceptor blocking agents do not cause retroperitoneal fibrosis.
腹膜后纤维化的病因尚不清楚。不时有不同药物被认为是其病因,包括β肾上腺素受体阻滞剂。对100例已诊断为腹膜后纤维化的住院患者的病历进行调查,以确定症状出现的日期、在此之前所开的药物以及入院时的血压。71例患者入院时舒张压为90毫米汞柱或更高,其中53例患者的舒张压至少为100毫米汞柱,尽管当时有14例患者正在服用抗高血压药物。6例患者在症状出现前接受过β肾上腺素受体阻滞剂治疗,另有24例患者随后接受了此类治疗。特别是,3例患者在诊断并进行手术后至少持续治疗了6年,腹膜后纤维化未复发。除β肾上腺素受体药物外,利尿剂和其他降压药物的服用量反映了高血压患者总体的用药模式。抗高血压药物可能不是致病因素,而是用于治疗与腹膜后纤维化相关的高血压,我们的研究结果表明β肾上腺素受体阻滞剂不会导致腹膜后纤维化。